Session » Reproductive Issues in Rheumatic Disorders Poster
-
Abstract Number: 1290
Preterm Birth Phenotypes in Women with Autoimmune Diseases
-
Abstract Number: 1291
Preterm Delivery Phenotypes in SLE Pregnancies
-
Abstract Number: 1292
Long-Term Follow-up of 320 Chilren Born to Mothers with Systemic Autoimmune Diseases: A Multicentre Survey from 24 Rheumatology Centers in Italy
-
Abstract Number: 1293
Indications for Cesarean Delivery in Systemic Lupus Erythematosus Pregnancies
-
Abstract Number: 1294
Time to Pregnancy in Women with Systemic Lupus Erythematosus
-
Abstract Number: 1295
Pregnancy Outcome in Patients with SLE Compared to Patients with Other Inflammatory Rheumatic Diseases: Real World Data from a Prospective Pregnancy Register
-
Abstract Number: 1296
Hydroxychloroquine Level Decreases throughout Pregnancy: Implications for Maternal and Neonatal Outcomes
-
Abstract Number: 1297
Hydroxychloroquine in Lupus Pregnancy: A Meta-Analysis of Individual Participant Data
-
Abstract Number: 1298
Tough Choices: Understanding the Medication Decision-Making Process for Women with Inflammatory Arthritis during Pregnancy and Lactation
-
Abstract Number: 1299
Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis
-
Abstract Number: 1300
The Italian Registry of Autoimmune Congenital Heart Block (Lu.Ne Registry): Report of the First Year of Activity
-
Abstract Number: 1301
Congenital Heart Defects in Children Born to Mothers with Rheumatic Disease and Anti-Ro and/or Anti-La Antibodies
-
Abstract Number: 1302
Luteinized Unruptured Follicle Syndrome in Young Female with Juvenile Idiopathic Arthritis
-
Abstract Number: 1303
Polycystic Ovarian Syndrome in Rheumatic Disease
-
Abstract Number: 1304
Lack of Uptake of Prophylactic Human Papilloma Virus (HPV) Vaccination Among Women with SLE in Saginaw Valley, a High Risk Population
-
Abstract Number: 1305
Use of Estrogen-Containing Contraceptives Among SLE Women with and without Contraindications to Estrogen
-
Abstract Number: 1306
Predictors of Contraceptive Use Among Reproductive-Age Women with Rheumatic Diseases
-
Abstract Number: 1307
Contraceptive Use in Patients with Rheumatologic Disease on Teratogenic Medications: Rate of Use and Related Factors
-
Abstract Number: 1308
Answering Reproductive Health Questions That Your Patients Want to Know: Impediments to Family Building and Risks of Contraception
-
Abstract Number: 1309
Characteristics and Outcomes of Prospectively Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database
-
Abstract Number: 1310
Maternal and Fetal Outcomes in a Cohort of Patients Exposed to Tumor Necrosis Factor Inhibitors throughout Pregnancy
-
Abstract Number: 1311
Pregnancy Outcome in Chinese Women with Rheumatic Disease Treated By Leflunomide (LEF)
-
Abstract Number: 1312
Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis; Hur-BIO Real Life Experiences
-
Abstract Number: 1313
Oral Corticosteroid Use during Pregnancy and Risk of Preterm Birth in Women with Rheumatoid Arthritis
-
Abstract Number: 1314
Pregnancy Outcomes in Patients with Psoriasis: A Nationwide Population-Based Study
-
Abstract Number: 1315
Influence of Rheumatoid Arthritis and Axial Spondyloarthritis on Pregnancy Complications, Pregnancy Outcome and Delivery Mode